Outokumpu


Solid Q2 22 results, with some caution going forward

04/08/22 -"The group has easily beaten its target of a higher EBITDA in Q2 vs Q1 22 This was of course based on firm prices This has enabled the company to deleverage its balance sheet further (which will ..."

Pages
63
Language
English
Published on
04/08/22
You may also be interested by these reports :
09/02/26
Our target price goes up substantially on the back of our earnings revision as well as long-term growth estimates, based on the new European measures ...

06/02/26
Aperam reported satisfactory results for FY25, although Q4 slightly underperformed expectations. More significantly, the anticipated impact of the ...

05/02/26
Sadly, Rio-Glencore have abandoned their merger talks. It is believed that Rio seeking the all-important Chairman and CEO roles in the combined firm ...

05/02/26
The change in the target price is due to a change in the analyst covering the stock, complemented by the usage of systematic intrinsic and peer-based ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO